AAAAAA

   
Results: 1-14 |
Results: 14
The risk of autoimmunity associated with tumor immunotherapy
Authors: Gilboa, E
Citation: E. Gilboa, The risk of autoimmunity associated with tumor immunotherapy, NAT IMMUNOL, 2(9), 2001, pp. 789-792
Induction of polyclonal prostate cancer-specific CTL using dendritic cellstransfected with amplified tumor RNA
Authors: Heiser, A Maurice, MA Yancey, DR Wu, NZ Dahm, P Pruitt, SK Boczkowski, D Nair, SK Ballo, MS Gilboa, E Vieweg, J
Citation: A. Heiser et al., Induction of polyclonal prostate cancer-specific CTL using dendritic cellstransfected with amplified tumor RNA, J IMMUNOL, 166(5), 2001, pp. 2953-2960
Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype
Authors: Nishimura, J Phillips, KL Ware, RE Hall, S Wilson, L Gentry, TL Howard, TA Murakami, Y Shibano, M Machiii, T Gilboa, E Kanakura, Y Takeda, J Kinoshita, T Fosse, WF Smith, CA
Citation: J. Nishimura et al., Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype, BLOOD, 97(10), 2001, pp. 3004-3010
Induction of cytotoxic T lymphocytes with dendritic cells transfected withhuman papillomavirus E6 and E7 RNA: Implications for cervical cancer immunotherapy
Authors: Thornburg, C Boczkowski, D Gilboa, E Nair, SK
Citation: C. Thornburg et al., Induction of cytotoxic T lymphocytes with dendritic cells transfected withhuman papillomavirus E6 and E7 RNA: Implications for cervical cancer immunotherapy, J IMMUNOTH, 23(4), 2000, pp. 412-418
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
Authors: Nair, SK Heiser, A Boczkowski, D Majumdar, A Naoe, M Lebkowski, JS Vieweg, J Gilboa, E
Citation: Sk. Nair et al., Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells., NAT MED, 6(9), 2000, pp. 1011-1017
Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: A liposome-mediated gene therapy treatment for bladder cancer
Authors: Larchian, WA Horiguchi, Y Nair, SK Fair, WR Heston, WDW Gilboa, E
Citation: Wa. Larchian et al., Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: A liposome-mediated gene therapy treatment for bladder cancer, CLIN CANC R, 6(7), 2000, pp. 2913-2920
Mass communication and diplomacy: A theoretical framework
Authors: Gilboa, E
Citation: E. Gilboa, Mass communication and diplomacy: A theoretical framework, COMMUN TH, 10(3), 2000, pp. 275-309
Phenotypic and functional maturation of dendrite cells mediated by heparansulfate
Authors: Kodaira, Y Nair, SK Wrenshall, LE Gilboa, E Platt, JL
Citation: Y. Kodaira et al., Phenotypic and functional maturation of dendrite cells mediated by heparansulfate, J IMMUNOL, 165(3), 2000, pp. 1599-1604
Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro
Authors: Heiser, A Dahm, P Yancey, DR Maurice, MA Boczkowski, D Nair, SK Gilboa, E Vieweg, J
Citation: A. Heiser et al., Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro, J IMMUNOL, 164(10), 2000, pp. 5508-5514
Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells
Authors: Boczkowski, D Nair, SK Nam, JH Lyerly, HK Gilboa, E
Citation: D. Boczkowski et al., Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells, CANCER RES, 60(4), 2000, pp. 1028-1034
The makings of a tumor rejection antigen
Authors: Gilboa, E
Citation: E. Gilboa, The makings of a tumor rejection antigen, IMMUNITY, 11(3), 1999, pp. 263-270
How tumors escape immune destruction and what we can do about it
Authors: Gilboa, E
Citation: E. Gilboa, How tumors escape immune destruction and what we can do about it, CANCER IMMU, 48(7), 1999, pp. 382-385
Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides
Authors: Nair, S Wearsch, PA Mitchell, DA Wassenberg, JJ Gilboa, E Nicchitta, CV
Citation: S. Nair et al., Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides, J IMMUNOL, 162(11), 1999, pp. 6426-6432
Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA
Authors: Nair, SK Hull, S Coleman, D Gilboa, E Lyerly, HK Morse, MA
Citation: Sk. Nair et al., Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA, INT J CANC, 82(1), 1999, pp. 121-124
Risultati: 1-14 |